PRCT fell 4.7% during a broad risk-off session as the S&P 500 and Nasdaq sold off and volatility jumped. The stock lagged its medical-device peers, which were higher, leaving the additional weakness without a company-specific dated driver. Boston Scientific's cluster of price-target cuts and Stryker's lowered outlook added a negative backdrop for medtech sentiment. Stryker lowered outlook after third-quarter profit fell
PRCT fell 4.7% during a broad risk-off session as the S&P 500 and Nasdaq sold off and volatility jumped. The stock lagged its medical-device peers, which were higher, leaving the additional weakness without a company-specific dated driver. Boston Scientific's cluster of price-target cuts and Stryker's lowered outlook added a negative backdrop for medtech sentiment. Stryker lowered outlook after third-quarter profit fell